Hexarelin 5mg
$45.00
Hexarelin 5mg is the standard single-vial format of the synthetic 6-amino-acid high-potency ghrelin-receptor agonist with characterised CD36-receptor activity for cardiovascular research. Greater than 99 percent HPLC verified.
100 in stock
Buy Hexarelin 5mg – Peptide Science
Hexarelin 5mg Overview
Hexarelin 5mg from Peptide Science is the standard single-vial format of the synthetic 6-amino-acid high-potency ghrelin-receptor agonist, supplied as a lyophilised powder for in-vitro pituitary and cardiovascular research. The 5 mg pack is the size most cited in published preclinical GHRP-class comparison work.
Compound Class and Mechanism
Hexarelin (sequence His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2) is a synthetic 6-amino-acid ghrelin-receptor agonist structurally based on the GHRP-6 backbone with a 2-methyl-tryptophan substitution at position 2 that increases receptor-binding affinity at GHS-R1a. Preclinical literature notes high in-vitro receptor potency and characterised additional activity at the CD36 scavenger receptor in cardiovascular cell-culture work, distinguishing it from the other GHRP-class members. Browse related compounds in the growth-hormone peptide range.
Vial Specifications
| Property | Value |
|---|---|
| Compound | Hexarelin |
| Class | Synthetic high-potency ghrelin-receptor agonist with CD36 activity |
| Amino-acid count | 6 |
| Molecular weight | approximately 887 g/mol |
| Supplied form | Lyophilised powder, sealed vial |
| Strength | 5 mg per vial |
| Purity | greater than 99 percent (HPLC and mass-spec verified) |
| Storage | 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term |
For the smaller 2 mg vial format, see Hexarelin 2mg. For combined-pathway research pairing Hexarelin with a GHRH analogue, see CJC-1295 No DAC plus Hexarelin 10mg Blend.
Reconstitution and Handling
The lyophilised vial reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard preclinical handling practice cited in pituitary-research literature, since repeated freeze-thaw cycles degrade short-sequence peptides.
Quality and Shipping
Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation against the theoretical molecular weight. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging via overnight or two-day courier.
For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws. Lyophilised vials store at 2 to 8 degrees Celsius; protect from light.


Reviews
There are no reviews yet.